Login / Signup

Recurrent giant cell tumour of the distal ulna after en bloc resection with preoperative denosumab use.

Nasa FujiharaShunsuke HamadaMasahiro YoshidaSatoshi Tsukushi
Published in: BMJ case reports (2021)
In recent years, denosumab has been used to treat giant cell tumour of bone (GCTB) not only in cases where surgery is complicated but also preoperatively to decrease the preoperative grade or to facilitate surgery for Campanacci grade II and III cases. However, there are no clear protocols regarding the preoperative use of denosumab before en bloc resection. There are a few reports of recurrent cases after en bloc resection; however, the association with the use of denosumab is unknown. We present the clinical, radiological and histopathological findings of a case of Campanacci grade III GCTB at the distal end of the ulna, which resulted in soft tissue recurrence after en bloc resection with the preoperative use of denosumab.
Keyphrases
  • giant cell
  • minimally invasive
  • patients undergoing
  • soft tissue
  • coronary artery bypass
  • emergency department
  • surgical site infection
  • percutaneous coronary intervention
  • acute coronary syndrome
  • postmenopausal women